A detailed history of Farther Finance Advisors, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 7,733 shares of INVA stock, worth $150,793. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,733
Previous 7,511 2.96%
Holding current value
$150,793
Previous $114 Million 11.69%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$14.4 - $16.4 $3,196 - $3,640
222 Added 2.96%
7,733 $128 Million
Q1 2024

May 13, 2024

BUY
$14.56 - $16.78 $107,438 - $123,819
7,379 Added 5590.15%
7,511 $114 Million
Q4 2023

Feb 14, 2024

SELL
$12.32 - $16.27 $147 - $195
-12 Reduced 9.09%
120 $1.93 Million
Q1 2023

May 13, 2024

BUY
$10.73 - $13.6 $128 - $163
12 Added 10.0%
132 $1.49 Million
Q4 2022

Sep 11, 2023

BUY
$11.8 - $13.78 $1,557 - $1,818
132 New
132 $1.75 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.36B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.